In this proof-of-concept study, we report that heterozygous inactivation of Dnmt3a restricted to the hematopoietic compartment exacerbates the development of colon cancer phenotype in an inflammation-induced mouse model. The gene discussed is DNMT3A; the disease is malignant colon neoplasm.